Investment Q&A

Q: What do think earnings will be for DELL on February 27th 2025

Do you recommend its purchase ? RAK

Q: The Cerebras IPO, that has been delayed since last year, looks very interesting. I wonder if 5i has a view on if/when it will happen and considers it attractive.
Having spent some time working on wafer scale integration, it is a far more complex and challenging problem than they make it sound like.
Appreciate your insight, Peter

Q: Rob's question regarding Constellation not issuing new shares and any other companies, I thought maybe BRK fit that or because of BRK.B guess not.

Also not to nitpick but CSU and GOOG can't be compared in the non issuing equity even though not a direct comparison as you did say "To our knowledge, GOOG has not issued shares other than for acquisitions, which is not quite the same" as GOOGLE has issued insane amounts of shares via SBC and of course they buyback to keep share count BUT Is there not a better way? BEN HUNT says it well I think:

"When stock buybacks are used to sterilize stock-based comp (i.e., a company gives managers stock with one hand and buys it back from them with the other hand), no money is “returned to shareholders”. This is true whether or not management actually sells its shares into the buyback program.
Stock buybacks only “return cash to shareholders” to the degree that the buyback program reduces the share count. To the degree the buyback program does not reduce the share count, but simply sterilizes new issuance to management, it is purely a transfer of wealth from shareholders to management."

Thoughts or rebuttal to that?

For readers on Constellation:
Mark Leonard was funded with 25 million from OMERS in 1995 to start, they had one private placement in 2000 that Leonard regrets for 60 million (TD Capital – Birch Hill and OMERS), then going public in 2006 no shares were issued just provided exit for OMERS/Birch Hill.

The best things about them among never issuing new shares for acquisitions etc is they have no Stock Based Compensation or RSU/ESO and that combo is not replicated anywhere (plus executives and employees having to buy stock with parts of their bonus and hold for 4 years is great alignment).

This along with numerous other factors are why its my highest holding and you never worry about it, ever, 10 years reading your answers and your views have never changed on this company, you have always been a big bull and wish I didn’t wait until 2022 to buy or really understand the company!

Q: Hello, can you please provide your opinion of IXJ and whether you think it is a buy at its current price.

Also, if there is a different US healthcare ETF that you think is better please provide advise why and what you think a good entry price is.

Thanks as always for the advice.
Paula

Q: Peter and His Wonder Team
I have never owned an auto stock. I realize competition is fierce and Telsa has an edge. However Ford is a survivor and is an American icon and so cheap...Please give the pros and cons of owning Ford. Or is the auto industry just too unpredictable to take a risk? Thanks for your assistance which is always valuable.

Q: Is BCE borrowing to pay the dividend?

Q: Hello
I am looking for an entry price for a partial position
the amzn.to (CD Canadian) could do too,
thanks
Michael

Q: Hi 5i,

Would you please provide your opinion on Vertex Pharmaceuticals (VRTX) as a 3-5 year investment.

Does their recent announcement related to an FDA approved non-addictive, non-opioid painkiller have promise?

If so, what would be the longer term implications for the company?

Thanks.

Q: Hi 5i
Another question on shopify... Earnings next week....What is expected and do you expect they will meet these earnings expectation?
Are you comfortable holding into earnings.... and would you expect any influence from Afrms positive results today Friday Feb 07

thx

Q: What do you expect from Brookfield on Feb 11?

Q: Any news or reason that this has jumped so much recently? I can't seem to find anything...
Thanks!

Q: Ignoring any crypto implications (I am decently invested in that area), do you think liberalizing the financial regulations in the US is likely to produce outsized short to medium term gains in that sector? If so, can you recommend a couple of solid names, a couple of speculative names and a couple of ETFs. Thanks again for the great service.

Q: Everyone, if you had a small amount of money, less than $50,000 how many ETF’s (no individual stocks only ETFs) would you have in your portfolio? Some question for amount of money above $100,000. And what sectors would they be in? Clayton

Q: Hi Peter & Team:
I found this Reuters article yesterday:
https://www.reuters.com/investigates/special-report/drugs-fentanyl-shipping/
Long article. It basically states that a very popular method for Fentanyl precursor chemicals to get stateside is via small value packages from China that are classed as “de minimus” and sail through US Customs at LAX airport with little documentation and hardly any inspection. (1 Billion small value boxes every year, think via ebay, etsy, etc most from China, many labeled as “gifts” or “stuff”.

Until a few days ago the de minimus limit for goods entering USA was 800$- it is now ZERO.
This I believe forces better documentation and allows for better inspection options. In Canada our de minimus limit remains at 20$ (at least as I write this note).

Question:
Assuming the de minimus limit for both USA and Canada are both set at ZERO, how will this e-commerce drag affect Shopify or e- commerce in general ?

Thanks for all you do !

Q: Please comment on the 3rd q and outlook. I listened to their conference call and it sounds like this is a growing business and they are leaders in their space.

Q: Hi, looking for some dividend growth. Can you provide some names you like that are forecasting ~5% dividend growth for the next 3-5 years? Thanks!

Q: Own GIS and after many year's I'm up 1% not including dividends ugh. How would you rate these in the sector?
Many thanks.

Q: Would welcome your analysis on this small cap- it has recently received some positive reports. It appears to be cash flow positive and has a new drug approval.

Q: I just wanted to say well done to 5i Research. Today I was watching CNBC and someone from Alger Funds was on talking about AI investing. Her name was Ankur Crawford. At the end of the piece, she was asked to give an AI investment. She named Nebius, and said it was completely under the radar, undiscovered, had great potential and "some of the greatest AI engineers in the world." You guys seemed to have beaten the crowd to this one. Now I have to try to buy it as it goes up tomorrow!

Q: Your assessment on their 4th. quarter. Cheers